COCHLEAR LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 320.8 AUD | +0.24% |
|
+1.62% | +7.40% |
| Apr. 22 | Cochlear Limited Announces Company Secretary Changes | CI |
| Apr. 19 | Cochlear Limited Receives Fda Clearance to Lower the Age for the Osia System to 5-Year-Old | CI |
Valuation
| Fiscal Period: Juni | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 11,938 | 12,410 | 16,546 | 13,070 | 15,043 | 21,009 | - | - |
| Enterprise Value (EV) 1 | 12,041 | 11,953 | 15,981 | 12,440 | 14,689 | 20,485 | 20,429 | 20,335 |
| P/E ratio | 43.1 x | -47.3 x | 50.7 x | 45.2 x | 50.1 x | 53.7 x | 47.9 x | 41.8 x |
| Yield | 1.6% | 0.85% | 1.01% | 1.51% | 1.44% | 1.3% | 1.49% | 1.68% |
| Capitalization / Revenue | 8.26 x | 9.18 x | 11.1 x | 7.93 x | 7.69 x | 9.23 x | 8.42 x | 7.78 x |
| EV / Revenue | 8.33 x | 8.84 x | 10.7 x | 7.55 x | 7.51 x | 9 x | 8.19 x | 7.53 x |
| EV / EBITDA | 29.5 x | 46.7 x | 39 x | 27.3 x | 30.8 x | 33.7 x | 29.8 x | 26.8 x |
| EV / FCF | 51 x | -44.4 x | 69.5 x | 37.5 x | 47 x | 57.8 x | 49 x | 41.9 x |
| FCF Yield | 1.96% | -2.25% | 1.44% | 2.67% | 2.13% | 1.73% | 2.04% | 2.39% |
| Price to Book | 16.4 x | 8.86 x | 9.72 x | 7.75 x | 8.63 x | 11.4 x | 10.6 x | 9.86 x |
| Nbr of stocks (in thousands) | 57,716 | 65,687 | 65,744 | 65,775 | 65,668 | 65,494 | - | - |
| Reference price 2 | 206.8 | 188.9 | 251.7 | 198.7 | 229.1 | 320.8 | 320.8 | 320.8 |
| Announcement Date | 8/15/19 | 8/17/20 | 8/19/21 | 8/18/22 | 8/14/23 | - | - | - |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,446 | 1,352 | 1,493 | 1,648 | 1,956 | 2,276 | 2,495 | 2,700 |
| EBITDA 1 | 408.6 | 256 | 409.7 | 455.7 | 477 | 607.4 | 685.1 | 759.8 |
| EBIT 1 | 370.1 | 206.9 | 330.2 | 382.7 | 396.1 | 522.3 | 593.8 | 666.4 |
| Operating Margin | 25.59% | 15.3% | 22.11% | 23.22% | 20.25% | 22.95% | 23.8% | 24.69% |
| Earnings before Tax (EBT) 1 | 365.6 | -271.1 | 365.7 | 393.8 | 396.6 | 534.3 | 596.9 | 671.6 |
| Net income 1 | 276.7 | -238.3 | 326.5 | 289.1 | 300.6 | 392.1 | 443.5 | 502.5 |
| Net margin | 19.13% | -17.62% | 21.86% | 17.54% | 15.37% | 17.22% | 17.78% | 18.62% |
| EPS 2 | 4.795 | -3.996 | 4.967 | 4.396 | 4.570 | 5.976 | 6.700 | 7.677 |
| Free Cash Flow 1 | 236.1 | -269.2 | 230.1 | 332 | 312.4 | 354.4 | 416.5 | 485.7 |
| FCF margin | 16.33% | -19.91% | 15.41% | 20.14% | 15.97% | 15.57% | 16.69% | 17.99% |
| FCF Conversion (EBITDA) | 57.78% | - | 56.16% | 72.85% | 65.49% | 58.34% | 60.8% | 63.93% |
| FCF Conversion (Net income) | 85.33% | - | 70.47% | 114.84% | 103.93% | 90.38% | 93.91% | 96.65% |
| Dividend per Share 2 | 3.300 | 1.600 | 2.550 | 3.000 | 3.300 | 4.155 | 4.775 | 5.381 |
| Announcement Date | 8/15/19 | 8/17/20 | 8/19/21 | 8/18/22 | 8/14/23 | - | - | - |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: June | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 755.7 | 574.7 | 742.8 | 750.5 | 815.3 | 833 | 885.2 | 1,070 | 1,098 | 1,185 | 1,210 | 1,269 |
| EBITDA 1 | - | 51 | 212.8 | 196.9 | 253.4 | 202.3 | 223 | 254 | 298 | 317.1 | - | - |
| EBIT 1 | 183.7 | 23.2 | 175.6 | 154.6 | 217.6 | 165.1 | 185.7 | 210.4 | 254.9 | 262 | 292.2 | 308.3 |
| Operating Margin | 24.31% | 4.04% | 23.64% | 20.6% | 26.69% | 19.82% | 20.98% | 19.65% | 23.2% | 22.11% | 24.15% | 24.3% |
| Earnings before Tax (EBT) | - | - | 238.9 | 126.8 | 230.9 | 162.9 | 187.7 | - | 260 | - | - | - |
| Net income 1 | 157.7 | -396 | 236.2 | 90.3 | 169.3 | 119.8 | 141.6 | 159 | 191.4 | 203.4 | 209.3 | 227.3 |
| Net margin | 20.87% | -68.91% | 31.8% | 12.03% | 20.77% | 14.38% | 16% | 14.85% | 17.42% | 17.17% | 17.3% | 17.91% |
| EPS 2 | 2.729 | -6.725 | 3.590 | 1.377 | 2.574 | 1.822 | 2.153 | 2.417 | 2.913 | 3.040 | 2.970 | 3.820 |
| Dividend per Share 2 | 1.600 | - | 1.150 | 1.400 | 1.550 | 1.450 | 1.550 | 1.750 | - | 2.170 | 234.0 | 257.0 |
| Announcement Date | 2/17/20 | 8/17/20 | 2/18/21 | 8/19/21 | 2/21/22 | 8/18/22 | 2/14/23 | 8/14/23 | 2/18/24 | - | - | - |
1AUD in Million2AUD
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 103 | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 457 | 565 | 629 | 354 | 523 | 580 | 674 |
| Leverage (Debt/EBITDA) | 0.2521 x | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 236 | -269 | 230 | 332 | 312 | 354 | 417 | 486 |
| ROE (net income / shareholders' equity) | 41.4% | 14.5% | 15.3% | 16.4% | 17.5% | 21.9% | 23.8% | 24.8% |
| ROA (Net income/ Total Assets) | 21.8% | 7.78% | 9.44% | 11.3% | 11.9% | 14.9% | 16.3% | 17.3% |
| Assets 1 | 1,268 | -3,064 | 3,458 | 2,552 | 2,517 | 2,626 | 2,727 | 2,900 |
| Book Value Per Share 2 | 12.60 | 21.30 | 25.90 | 25.60 | 26.50 | 28.20 | 30.30 | 32.50 |
| Cash Flow per Share 2 | 5.130 | -2.650 | 4.130 | 5.720 | 5.500 | 6.610 | 7.740 | 8.630 |
| Capex 1 | 59.9 | 111 | 41.2 | 44.5 | 50 | 74 | 76.3 | 81.1 |
| Capex / Sales | 4.14% | 8.24% | 2.76% | 2.7% | 2.56% | 3.25% | 3.06% | 3% |
| Announcement Date | 8/15/19 | 8/17/20 | 8/19/21 | 8/18/22 | 8/14/23 | - | - | - |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
16
Last Close Price
320.8
AUD
Average target price
280.9
AUD
Spread / Average Target
-12.42%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.40% | 13.7B | |
| +1.84% | 24.07B | |
| +10.34% | 10.18B | |
| -17.75% | 2.06B | |
| +6.38% | 1.79B | |
| +41.47% | 1.73B | |
| +13.26% | 589M | |
| 0.00% | 400M | |
| +27.40% | 135M | |
| +21.80% | 93.49M |
- Stock Market
- Equities
- COH Stock
- Financials Cochlear Limited
